The University of Chicago Header Logo

Connection

Benjamin Derman to B-Cell Maturation Antigen

Back to Details
This is a "connection" page, showing publications Benjamin Derman has written about B-Cell Maturation Antigen.
Benjamin Derman
Connection Strength
0.237
B-Cell Maturation Antigen
  1. Phase 1 clinical trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myeloma. Leukemia. 2025 Apr; 39(4):816-826.
    View in: PubMed
    Score: 0.237
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.